Roskamp Institute Seeks To Help A Rapidly Aging Population

The world is aging at a steady and inexorable pace thanks to major advances in the fields of medicine, nutrition and public hygiene. The quality of life has improved dramatically over the past few decades and various diseases have been eliminated during the same period. However, a rapidly aging population also brings about various demographic challenges. Not only do people desire to live better and not just longer lives but governments also fear increasing public health costs that arise from having an elderly population. While age related deterioration is the unintended disadvantage of leading a long life, it doesn’t always have to be this way. The Roskamp Institute based in Sarasota, Florida is at the forefront of the march towards healthy aging. 

It is an unfortunate but scientific fact that the brain begins to shrink as one age and this results in a curtailment of various bodily and mental functions. There are also changes in the structure of the brain that reduce the ability to communicate between neurons. Further, there is also a reduction in blood supply to the brain because arteries become narrow. In addition to all of the above, the brain also gets damaged by free radicals which are responsible for inflammation in tissues. All in all, it becomes very difficult for a very elderly person to enjoy a rich and varied life since many complex functions can no longer be performed by the body and mind. Most degenerative diseases of the brain appear at around 60 years of age, with the chances of getting them increasing exponentially as one grows older.

 The Roskamp Institute’s Dr. Michael Mullan has built up a formidable reputation in the field of Alzheimers research and he has devoted his efforts to finding solutions to various neurodegenerative disorders by developing effective drug therapies for them. Addiction is another area of interest at this institute and this too has very important ramifications for society. The research teams at this institute have already been able to greatly increase our understanding of these diseases, leaving the way open to finding cures in the future. As of now, it has become possible to reduce the severity of symptoms even though cures are not always possible. Identifying the symptoms correctly and diagnosing diseases during their early stages will ensure that treatments can be started as quickly as possible.

It is safe to say that it is only a matter of time before drugs will easily be available for various neurological based psychiatric and degenerative diseases. In fact, the great importance of the path breaking work undertaken at this institute is underlined by the fact that it receives a great deal of funding from many private and government sources. 

Dr. Michael Mullan is introducing a very important aspect regarding Alzheimer's disease  which is very dangerous disease for both man and women in old age.

Michael Mullan Research Scientist at Roskamp

Dr. Michael Mullan is distinguished face of biomedical science. He is widely known for his research work for Swedish mutation present in familial form. He is well known for his developmental work in therapeutic cures for Alzheimer’s disease. His arrays of interests have always been neuroscience, drug development, cognitive development, brain health and neuropsychiatric diseases.

Dr. Mullan acquired his initial education in 1984 from the Royal Free School of Medicine where he was also positioned as the President of the Royal Free Mental Handicap Society. After graduating, he practiced as a Surgeon and later on took the position in psychiatry at Friar Hospital in London. Subsequently to further increase his experience he joined Middlesex Hospital Medical School where he was positioned as a researcher in Molecular Genetic Study of Alzheimer’s disease. It was from there that he kept on developing interest and desire to find a cure for this disease. Dr. Mullan has also served as an Honorary Clinical Research Registrar at St. Mary’s Hospital and The National Hospital for Nervous Diseases. In 1992, Dr. Mullan joined University of South Florida and thus established Roskamp Laboratories. In 2003, Roskamp Institute relocated to Sarasota, Florida where Dr. Mullan served as the Director and conducted various researches on Alzheimer’s disease. 

Dr. Michael Mullan in association with his colleague Dr. Fiona Crawford made the discovery of Swedish mutation and let to find the initial cause of the Alzheimer’sdisease. They together had created the first animal model for Alzheimer’s disease. His major research works includes investigating the role of beta amyloid in inflammation and determining the CD40-CD40L signaling pathways associated with Alzheimer’s disease pathogenesis. He has acquired several patents to his name and numerous publications. 

Serving at directorial positions of various organizations, he is currently the CEO and Chairman of the Board of Rockcreek Pharmaceuticals. As the founder of Roskamp institute in Sarasota, Florida, Dr. Mullan’s leadership led to cutting edge development in neuropsychiatric illnesses. His research work was funded by multiple agencies including the NIH and the Department of defense. 

Dr. Michael Mullan works mainly on Alzheimer’s disease but he is just not limited till there. He has served for finding cures in childhood metal illness and disorders like Tourette’s syndrome, Autism, Gulf war illness, Traumatic Brain Injury and Drug Addiction. His work in the field of biomedical research is very noticeable. He has served for the betterment of a vast majority of the community. Most of patients of Alzheimer’s disease are the elderly 60 plus. And preserving the life experiences is one contribution of his for the nation. Many patients reminisce about their past and it is very hard to see them with fading memories. Patients suffering from Alzheimer’s disease face the most traumatic loss as they keep forgetting their recent past as well as their family and friends. Dr. Mullan’s work has tremendously contributed towards developing FDA approved drugs for such patients and new developments are still going on at the Roskamp institute in Florida.

To successfully cure neuropsychiatric diseases and promote healthy aging, Dr. Michael Mullan founded the Roskamp Institute with the same mission and to conduct safe and effective drug therapies. He has been a successful figure in the biomedical science and is achieving great heights in his work.

Roskamp Institute – Attempting Alzheimer through Objective Researches

Health is a gift for the mind, body and soul and is the true wealth to cherish. However, this gifted wealth often gets aberrated due to disease conditions. If the person is lucky enough, then he can get cured with the available line of drugs; however, there are certain illnesses, the cures for which have remained elusive after long and dedicated researches.

Alzheimer disease is characterized by most of the dementia symptoms such as the memory degradation, visual losses, locomotor losses and identification problems among others. The pitiful aspect of Alzheimer is that most of the symptoms and manifestations are sidelined as that of old age in a very commonly accepted norm, thus leaving the aged person to struggle. The more educated and aware societies of the world have shown greater rates of diagnosis, if not the incidence.

Finding out the fundamental factors

The med community has been engaged in quality and deeper researches so as to establish the reasons, but the cure is still far away. There have been some authentic insight, of course, from some noted quarters like the Roskamp Institute of US. This not for profit research institute has under the inspiring leadership of Michael Mullan produced valuable leads as for understanding some correlations between Alzheimer and associated factors.

Dr Mullan is considered a global authority on Alzheimer research because of his pioneering studies that helped establish the role of beta amyloid protein which he found is overproduced due to a genetic inconsistency. Greater the production of this protein, greater would be the progression rate of the disease.

 Running associated programs for holistic research

Michael Mullan is the CEO of Sarasota based Roskamp Institute and has been guiding the next phase of the researches to bring out more insights through dedicated programs of direct consonances. The institute runs its ‘Vision Research Program’ that is oriented towards studying the visual impairments in the dementia and Alzheimer by studying the patterns of visual cortex and optical nerves over the time in the Alzheimer patients.

The Institute also runs Memory Clinics where objective counseling is offered with the aim of arresting the disease progression. The Roskamp Institute also studies the effect of the potential risk factors as for Alzheimer disease such as the head injuries, family history, depression and hypertension among others. Such correlations have proved to be beneficial as for prescribing the care suggestions for the person where already the onset has been diagnosed.

Carrying out effective yet ethical clinical trials -

The research maneuvers of the Institute are complemented by the ‘Clinical Trials Division’ of it which is an attempt to collect the most authentic of the databases from the willing volunteers in an ethical manner. The volunteers are offered potential cures free of cost together with effective cushioning against the side effects.

 Michael Mullan has established some of the finest standards in this Sarasota institute which is escorting the care and cure attempts with the best of the Biomedical Researcher community at its end. The findings of this Institute have been validated by noted journals that demonstrate the efficacies.

Michael Mullan, The World's Leading Neuroscientist

A lot of research has been going on in the field of Alzheimer's and brain development. And, one of the leading institutes doing this research is Roskamp Institute. Based out of Sarasota in United States, is an non-profit organization, which is committed towards discovering and treating neuropsychiatric as well as neuro-degenerative disorders.

Michael Mullan happens to be the director of this prestigious institute. Dr. Mullan was born in 1956 in Kent. He did his graduation in Medicine and Surgery from London University. He did his post-graduation in Psychiatry from Royal college in 1990. Then, he did his PhD in Philosophy, specializing in Molecular Genetics from London University, in the year 1993.

Career of Dr. Mullan:
Michael began his career in the year 1988 and worked for 3 years in a major teaching hospital in London named The Royal Free Hospital. Then, he worked as senior registrar with the Psychiatric hospital named Friern Hospital. He has also worked as Professor for Biological Psychiatry, and professor in Department of Neurology and Pathology. He is the CEO of Roskamp-Institute in Florida currently. He has been the main person behind the research on Alzheimer's disease. He holds around 12 patents in total. And, he has published about 200 scientific studies in the past 3 decades. And, all these published materials are on Alzheimer's disease, neuropathy of dementia, molecular genetics, manic-depression, alcoholism, schizophrenia, etc. He has received a number of awards and honours for all his research work.

Dr. Mullan is the bio-medical researcher of Beta Amyloid Protein. And, he has been working on its relation with Alzheimer's disease. His research is quite well known in the bio-medical community. Due to his research, Swiss Mutation has been identified. The transgenic animals for the Alzheimer's makes use of the Swedish Mutation. The institute, which is headed by Dr. Mullan and Dr. Fiona Crawford, has been dedicated towards the research. The institute has various experienced scientists, technicians and the most-updated equipment and tools for conducting the scientific research. And, the research quality is also the best. As per them, better science leads to a real discovery. The mission of this institute is conducting the scientific research so that safer and more effective drugs can be taken out for treating the mind-related diseases. 

The Roskamp institute in Sarasota has a wide range of technical innovative advancements. And, under the leadership of Dr. Mullan, there are about 70 clinicians, scientists, students, and other administrative staff, who work together for pursuing the research so that the source of the neurological disorders can be found out. And, once the cause is found out, the future treatments can be devised. The institute is dedicated towards discovering safe and effective drug therapies. With the help of these therapies, the aging can happen in an healthy manner.

With the efforts of Dr. Mullan, the Neuroscientist, there has been a lot of work towards improvement of the diagnosis of Alzheimer's patients. So, anybody, who is suffering from a disease of the mind, can find the appropriate help and guidance from here.

Understanding the Possibilities of Curing Alzheimer Disease

Medical Treatment

It is a fact that presently, there exists no medicine for treating Alzheimer disease. At the same time, it is not possible to prevent the disease or have effective treatments for it. However, there are present few non-drug and drug treatments, which do provide relief on a temporary basis for both cognitive and behavioral symptoms.

Cholinesterase Inhibitors

These are known to assist in preserving the capability of the sick nerve endings for transmitting nerve messages to next cell present in chain.

Neurotransmitter Acetylcholine

In regards to this disease, one of the most vital neurotransmitter is said to be acetylcholine (which is actually a very small blip of chemical that diffuses quite rapidly across junctions of the nerve cell for stimulating the next cell), which is utilized by nerve cells in brain part to think and for memory making. At the same time, it is equally essential that acetylcholine gets eliminated at the earliest after the message has been carried across junction. In case, it is not, then it is likely to keep on stimulating downstream cell. It can be disastrous, while leading to possible attacks.

Disturbance in Degradation Process

Generally, acetylcholine gets destroyed instantly after delivering the message by an enzyme known as cholinesterase. In Alzheimer’s, nerve cell endings could get much sicker and acetylcholine amount that is produced by every nerve impulse could get lesser and lesser with the progress of the disease.

What does Cholinesterase Inhibitors do?

Cholinesterase inhibitors which are utilized as Alzheimer’s cure might restrain destroying by cholinesterase of acetylcholine, which results in acetylcholine level getting high enough for getting the message over the next cell.

Temporary Solution

However, this would not work forever. Over a period of time, sick nerve endings tend to start degenerating and withdrawing from junctions. The messages not longer could be transferred. Generally, it takes around 2 to 3 years before the situation gets reached (occasionally it tends to last much longer). It explains as to why cholinesterase inhibitors generally work on a temporary basis.

Researching on Treatment of the Disease

Scientists at Sarasota camp are continuing with the research for coming up with treatments that are effective and for holding the disease off, quickly. By researching on the web, one can get few examples. Article regards to Nature Genetics does mention identification of more five genes behind this disease by a research consortium.

The experts at Michael Mullan have been trying to come up with researches for understanding the events which leads towards damage of bigger brain parts and eventually complete loss of the cognitive abilities. According to a published article in a leading Journal, insulin can have a new, powerful role to fight the disease. The article describes new clinical researches done by the experts that found that low insulin dose is found to suppress successfully the expression in blood of 4 precursor proteins that are involve in pathogenesis of the disease.

The roskamp institute states that it has been working on to come up with novel cures having the capability to slow down the progression rate of the disease and try to eradicate it in the near future.

For More Details Visit Here: Michael Mullan